Medivolve Inc. (4NC.F) Comparison with companies in other sectors?

Medivolve Inc. has a share price of N/A. You can analyze Medivolve Inc. (4NC.F) competitors across different market sectors through stock heatmaps.

What are 4NC.F's NET and operating margins?

Medivolve Inc. (4NC.F) operating margin is around N/A, and net profit margin is approximately N/A as of the latest reports.

In what way does 4NC.F's earnings per share (EPS) trend reflect its financial momentum?

Medivolve Inc. (4NC.F) EPS is 0.05 (If EPS value is positive, then "signals consistent profit growth" if Negative then "signals consistent loss"). This metric is also critical in assessing valuation metrics like the P/E ratio for Medivolve Inc. is 0.07, and the company's ability to reinvest or distribute profits.

What does a high ROE mean for Medivolve Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Medivolve Inc. like P/E which is N/A, P/B which is N/A, and PEG which is N/A. Compare them with sector averages to evaluate if the stock is priced fairly.

Medivolve Inc.

Get $10 bonus on your first $100 deposit for 4NC.F

4NC.F•XETRA

Healthcare

Medical - Diagnostics & Research

Get $10 bonus on your first $100 deposit for 4NC.F

€0.004

€0.00(0.00%)

German Market is Open • 13:01

Medivolve Inc. Fundamental Analysis

Medivolve Inc. (4NC.F) shows weak financial fundamentals with a PE ratio of 0.07, profit margin of N/A, and ROE of N/A. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

No significant strengths identified.

Areas of Concern

No major concerns flagged.

We analyze 4NC.F's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 0.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

0.0/100

We analyze 4NC.F's fundamental strength across five key dimensions:

Efficiency Score

Weak

4NC.F struggles to generate sufficient returns from assets.

ROA > 10%

N/A

Valuation Score

Moderate

4NC.F shows balanced valuation metrics.

PE < 25

0.07

PEG Ratio < 2

N/A

Growth Score

Moderate

4NC.F shows steady but slowing expansion.

Revenue Growth > 5%

N/A

EPS Growth > 10%

N/A

Financial Health Score

Weak

4NC.F carries high financial risk with limited liquidity.

Debt/Equity < 1

N/A

Current Ratio > 1

N/A

Profitability Score

Weak

4NC.F struggles to sustain strong margins.

ROE > 15%

N/A

Net Margin ≥ 15%

N/A

Positive Free Cash Flow

N/A

Key Financial Metrics

Is 4NC.F Expensive or Cheap?

P/E Ratio

4NC.F trades at 0.07 times earnings. This suggests potential undervaluation.

0.07

How Well Does 4NC.F Make Money?

No data available.

Following the Money - Real Cash Generation

No data available.

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

N/A

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

N/A

vs 25 benchmark

P/B Ratio

Price to book value ratio

N/A

vs 25 benchmark

P/S Ratio

Price to sales ratio

N/A

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

N/A

vs 25 benchmark

Current Ratio

Current assets to current liabilities

N/A

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

N/A

vs 25 benchmark

ROA

Return on assets percentage

N/A

vs 25 benchmark

ROCE

Return on capital employed

N/A

vs 25 benchmark

How 4NC.F Stacks Against Its Sector Peers

Metric	4NC.F Value	Sector Average	Performance
P/E Ratio	N/A	29.17	N/A
ROE	N/A	701.00%	N/A
Net Margin	N/A	-43676.00% (disorted)	N/A
Debt/Equity	N/A	0.34	N/A
Current Ratio	N/A	4.45	N/A
ROA	N/A	-18965.00% (disorted)	N/A

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Medivolve Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Medivolve Inc. Fundamental Analysis

Key Strengths

Areas of Concern

Fundamental Health Score

Efficiency Score

Valuation Score

Growth Score

Financial Health Score

Profitability Score

Key Financial Metrics

Is 4NC.F Expensive or Cheap?

How Well Does 4NC.F Make Money?

Following the Money - Real Cash Generation

Financial Ratios Analysis

Valuation Ratios

Financial Health

Efficiency Ratios

How 4NC.F Stacks Against Its Sector Peers

Historical Growth Performance

5-Year Growth Trajectory

Fundamental Analysis FAQ

Medivolve Inc. (4NC.F) Comparison with companies in other sectors?

What are 4NC.F's NET and operating margins?

In what way does 4NC.F's earnings per share (EPS) trend reflect its financial momentum?

What does a high ROE mean for Medivolve Inc.?

How do I know if AAPL is overvalued or undervalued?